10
Fig. 1 Timeline of CRISPR-Cas and genome engineering research fields.Key developments in both fields are shown. Jennifer A. Doudna, and Emmanuelle Charpentier Science 2014;346:1258096 Published by AAAS

Fig. 1 Timeline of CRISPR-Cas and genome engineering research fields.Key developments in both fields are shown. Jennifer A. Doudna, and Emmanuelle Charpentier

Embed Size (px)

Citation preview

Page 1: Fig. 1 Timeline of CRISPR-Cas and genome engineering research fields.Key developments in both fields are shown. Jennifer A. Doudna, and Emmanuelle Charpentier

Fig. 1 Timeline of CRISPR-Cas and genome engineering research fields.Key developments in both fields are shown.

Jennifer A. Doudna, and Emmanuelle Charpentier Science 2014;346:1258096

Published by AAAS

Page 2: Fig. 1 Timeline of CRISPR-Cas and genome engineering research fields.Key developments in both fields are shown. Jennifer A. Doudna, and Emmanuelle Charpentier

Fig. 2 Biology of the type II-A CRISPR-Cas system.The type II-A system from S. pyogenes is shown as an example.

Jennifer A. Doudna, and Emmanuelle Charpentier Science 2014;346:1258096

Published by AAAS

Page 3: Fig. 1 Timeline of CRISPR-Cas and genome engineering research fields.Key developments in both fields are shown. Jennifer A. Doudna, and Emmanuelle Charpentier

Fig. 3 Evolution and structure of Cas9.The structure of S. pyogenes Cas9 in the unliganded and RNA-DNA–bound forms [from (77, 81)].

Jennifer A. Doudna, and Emmanuelle Charpentier Science 2014;346:1258096

Published by AAAS

Page 4: Fig. 1 Timeline of CRISPR-Cas and genome engineering research fields.Key developments in both fields are shown. Jennifer A. Doudna, and Emmanuelle Charpentier

Fig. 4 CRISPR-Cas9 as a genome engineering tool.(A) Different strategies for introducing blunt double-stranded DNA breaks into genomic loci, which become substrates for

endogenous cellular DNA repair machinery that catalyze nonhomologous end joining (NHEJ) or homology-directed repair (HDR).

Jennifer A. Doudna, and Emmanuelle Charpentier Science 2014;346:1258096

Published by AAAS

Page 5: Fig. 1 Timeline of CRISPR-Cas and genome engineering research fields.Key developments in both fields are shown. Jennifer A. Doudna, and Emmanuelle Charpentier

Fig. 5 Examples of cell types and organisms that have been engineered using Cas9.

Jennifer A. Doudna, and Emmanuelle Charpentier Science 2014;346:1258096

Published by AAAS

Page 6: Fig. 1 Timeline of CRISPR-Cas and genome engineering research fields.Key developments in both fields are shown. Jennifer A. Doudna, and Emmanuelle Charpentier

Fig. 6 Future applications in biomedicine and biotechnology.Potential developments include establishment of screens for target identification, human gene therapy by gene repair and

gene disruption, gene disruption of viral sequences, and programmable RNA targeting.

Jennifer A. Doudna, and Emmanuelle Charpentier Science 2014;346:1258096

Published by AAAS

Page 7: Fig. 1 Timeline of CRISPR-Cas and genome engineering research fields.Key developments in both fields are shown. Jennifer A. Doudna, and Emmanuelle Charpentier

David Baltimore et al. Science 2015;348:36-38

Published by AAAS

Page 8: Fig. 1 Timeline of CRISPR-Cas and genome engineering research fields.Key developments in both fields are shown. Jennifer A. Doudna, and Emmanuelle Charpentier

How endonuclease gene drives spread altered genes through populations.(A) Altered genes (blue) normally have a 50% chance of being inherited by offspring when crossed with a wild-

type organism (gray).

Kenneth A. Oye et al. Science 2014;345:626-628

Published by AAAS

Page 9: Fig. 1 Timeline of CRISPR-Cas and genome engineering research fields.Key developments in both fields are shown. Jennifer A. Doudna, and Emmanuelle Charpentier

Kenneth A. Oye et al. Science 2014;345:626-628

Published by AAAS

Page 10: Fig. 1 Timeline of CRISPR-Cas and genome engineering research fields.Key developments in both fields are shown. Jennifer A. Doudna, and Emmanuelle Charpentier